Related Experiment Videos
Peripheral giant cell granuloma: evidence for osteoclastic differentiation
F Bonetti1, G Pelosi, G Martignoni
1Instituto di Anatomia Patologica, Università di Verona, Italy.
Oral Surgery, Oral Medicine, and Oral Pathology
|October 1, 1990
Summary
Peripheral giant cell granulomas contain unique giant cells. These cells are distinct from those in chronic inflammation and may be true osteoclasts, according to immunohistochemical analysis.
Area of Science:
- Oral pathology
- Cell biology
- Immunohistochemistry
Background:
- Peripheral giant cell granuloma (PGCG) is a common reactive lesion in the oral cavity.
- The cellular origin of the multinucleated giant cells in PGCG has been debated.
- Understanding giant cell phenotype is crucial for PGCG pathogenesis.
Purpose of the Study:
- To investigate the immunophenotype of giant cells in oral peripheral giant cell granulomas.
- To determine if these giant cells share characteristics with macrophages or osteoclasts.
Main Methods:
- Immunohistochemical analysis of nine PGCG tissue samples.
- Utilized antibodies against myelomonocytic/macrophage markers (lysozyme, MAC 387, HAM 56).
- Used MB1 antibody, known to react with osteoclasts.
Main Results:
- Giant cells in PGCG showed no reactivity with myelomonocytic or macrophage markers.
- Strong immunoreactivity was observed with MB1, an osteoclast-associated marker.
- This suggests a distinct phenotype for PGCG giant cells.
Conclusions:
- Giant cells in peripheral giant cell granuloma exhibit a unique phenotype.
- These cells are distinct from giant cells typically found in chronic inflammation.
- The findings suggest that PGCG giant cells may represent true osteoclasts.